Relaxant effects of sodium nitroprusside and NONOates in rabbit basilar artery

Pharmacology

Volumn 57, Issue 2, 1998, Pages 79-87

  Salom, Juan B ^a,b   Barberá, María D ^b   Centeno, José M ^a,b   Ortí, Marta ^a,b   Torregrosa, Germán ^a,b   Alborch, Enrique ^a,b  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Basilar artery, rabbit; Nitric oxide donors; Vasorelaxation

Indexed keywords

ACETYLCHOLINE; CYCLIC GMP; DIETHYLAMINE; DIETHYLENETRIAMINE; HISTAMINE; METHYLENE BLUE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; POTASSIUM CHLORIDE; SPERMINE DERIVATIVE; URIDINE TRIPHOSPHATE;

ANIMAL TISSUE; ARTERY TONE; ARTICLE; BASILAR ARTERY; BRAIN BLOOD VESSEL; CONTROLLED STUDY; DEPOLARIZATION; DRUG POTENCY; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 0031901875     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000028228     Document Type: Article

References (26)

1. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-142.
2. Moncada S, Higgs EA: Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J 1995;9:1319-1330.
3. Morley D, Keefer LK: Nitric oxide/ nucleophile complexes: A unique class of nitric oxide-based vasodilators. J Cardiovasc Pharmacol 1993; 22(suppl 7):3-9.
4. Ferioli R, Folco GC, Ferretti C, Gasco C, Medana R, Fruttero M, Civelli M, Gasco A: A new class of furoxan derivatives as NO donors: Mechanism of action and biological activity. Br J Pharmacol 1995;114: 816-820.
5. Maragos CM, Morley D, Wink DA, Dunams TM, Saavedra JE, Hoffman A, Bove AA, Isaac L, Hrabie JA, Keefer LK: Complexes of NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects. J Med Chem 1991;34:3242-3247.
6. Dawson DA: Nitric oxide and focal cerebral ischemia: Multiplicity of actions and diverse outcome. Cerebrovasc Brain Metab Rev 1994;6: 299-324.
7. Faraci FM, Brian JE: Nitric oxide and the cerebral circulation. Stroke 1994;25:692-703.
8. Iadecola C, Pelligrino DA, Moskowitz MA, Lassen NA: Nitric oxide synthase inhibition and cerebrovascular regulation. J Cereb Blood Flow Metab 1994;14:175-192.
9. Katušić ZS, Cosentino F: Nitric oxide synthase: From molecular biology to cerebrovascular physiology. News Physiol Sci 1994;9:64-67.
10. Watkins LD: Nitric oxide and cerebral blood flow: an update. Cerebrovasc Brain Metab Rev 1995;7: 324-337.
11. Jenkinson DH, Barnard EA, Hoyer D, Humphrey PPA, Leff P, Shankley NP: International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. IX. Recommendations on terms and symbols in quantitative pharmacology. Pharmacol Rev 1995;47:255-266.
12. Tallarida RJ, Murray RB: Manual of Pharmacologic Calculations with Computer Programs. New York, Springer, 1987.
13. Feelisch M: The biochemical pathways of nitric oxide formation from nitrovasodilators: appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous NO solutions. J Cardiovasc Pharmacol 1991;17(suppl 3): 25-33.
14. Morley D, Maragos CM, Zhang XY, Boignon M, Wink DA, Keefer LK: Mechanism of vascular relaxation induced by the nitric oxide (NO)/ nucleophile complexes, a new class of NO-based vasodilators. J Cardiovasc Pharmacol 1993;21:670-676.
15. Kowaluk EA, Seth P, Fung HL: Metabolic activation of sodium nitroprusside to nitric oxide in vascular smooth muscle. J Pharmacol Exp Ther 1992;262:916-922.
16. Moncada S, Rees DD, Schulz R, Palmer RMJ: Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo. Proc Natl Acad Sci USA 1991;88:2166-2170.
17. Govantes C, Rodríguez-Martínez MA, Marin J: Vasodilator effect and tolerance induced by the nitrocompound SIN-1 in rabbit femoral artery. Methods Find Exp Clin Pharmacol 1996;18:387-395.
18. García-Villalón AL, Fernández N, Monge L, García JL, Gómez B, Diéguez G: Role of nitric oxide and potassium channels in the cholinergic relaxation of rabbit ear and femoral arteries: Effects of cooling. J Vasc Res 1995;32:387-397.
19. Ferrer M, Encabo A, Conde MV, Marín J, Balfagón G: Heterogeneity of endothelium-dependent mechanisms in different rabbit arteries. J Vasc Res 1995;32:339-346.
20. Rapoport RM, Schwartz K, Murad F: Effect of sodium-potassium pump inhibitors and membrane-depolarizing agents on sodium nitroprusside-induced relaxation and cyclic guanosine monophosphate accumulation in rat aorta. Circ Res 1985;57:164-170.
21. Bohn H, Brendel J, Martorana PA, Schönafinger K: Cardiovascular actions of the furoxan CAS 1609, a novel nitric oxide donor. Br J Pharmacol 1995;114:1605-1612.
22. Bolotina VM, Najibi S, Palacino JJ, Pagano PJ, Cohen RA: Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 1994;368: 850-853.
23. G-nitro-L-arginine and diphenyleneiodonium. Br J Pharmacol 1995;114:194-202.
24. Diodati JG, Quyyumi AA, Hussain N, Keefer LK: Complexes of nitric oxide with nucleophiles as agents for the controlled biological release of nitric oxide: Antiplatelet effect. Thromb Haemost 1993;70:654-658.
25. Zhang F, White JG, Iadecola C: Nitric oxide donors increase blood flow and reduce brain damage in focal ischemia: Evidence that nitric oxide is beneficial in the early stages of cerebral ischemia. J Cereb Blood Flow Metab 1994;14:217-226.
26. Chi OZ, Wei HM, Weiss HR: Effects of CAS 754, a new nitric oxide donor, on regional cerebral blood flow in focal cerebral ischemia. Anesth Analg 1995;80:703-708.